Anti-inflammatory effects of jojoba liquid wax in experimental models

Pharmacological Research

Volumn 51, Issue 2, 2005, Pages 95-105

  Habashy, Ramy R ^a   Abdel Naim, Ashraf B ^a   Khalifa, Amani E ^a   Al Azizi, Mohammed M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Anti inflammatory; Jojoba liquid wax; Myeloperoxidase; Prostaglandin E2

Indexed keywords

ANTIINFLAMMATORY AGENT; CROTON OIL; INDOMETACIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NITRIC OXIDE; PLANT EXTRACT; SIMMONDSIA CHINENSIS EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DRUG EFFICACY; EAR DISEASE; EDEMA; ENZYME ACTIVITY; EXPERIMENTAL MODEL; GRANULOMATOSIS; HISTOPATHOLOGY; INFLAMMATION; MEDICINAL PLANT; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT; SIMMONDSIA CHINENSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; EDEMA; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS; WAXES;

EID: 11144326726     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2004.04.011     Document Type: Article

References (52)

1. Hogan L. Jojoba: new crop for arid regions of the world? Crops Soils Mag. 31(2):1978;18-19
2. Davidson S. Jojoba: cautious optimisim. Rural Res. 119:1983;21-25
3. Borlaug N, Baldwin AR, Estefan R, Harris M, Plucknett DL. Jojoba: new crop for arid lands. New raw material for industry. Washington, DC: National Academy Press; 1985. p. 6, 13.
4. Van Boven M., Daenens P., Maes K., Cokelaere M. Content and composition of free sterols and free fatty alcohols in jojoba oil. J. Agric. Food Chem. 45:1997;1180-1184
5. Miwa T.K. Structural determination and uses of jojoba oil. J. Am. Oil Chem. Soc. 61(2):1984;407-410
6. Kampf A., Gringberg S., Galuun A. Oxidative stability of jojoba wax. J. Am. Oil Chem. Soc. 63:1986;246-248
7. Yaron A. Metabolism and physiological effects of jojoba oil. In: Wisniak J, editor. The chemistry and technology of jojoba oil. Champaign, IL: American Oil Chemists' Society Press; 1987. p. 251-65.
8. Taguchi N., Kunimoto T. Toxicity studies on jojoba oil for cosmetic uses. Cosmet. Toilet. 92:1977;53-62
9. Heise C., Decombaz J., Anantharaman K. Energy value of jojoba oil for the growing rat. Int. J. Vitam. Nutr. Res. 52:1982;216-221
10. Yaron A., Benzioni A. Absorption and distribution of jojoba wax injected subcutaneously into mice. Lipids. 15:1980;889-894
11. Mosovich B. Treatment of acne and psoriasis. In: Wisniak J, Zabicky J, editors. Proceedings of the Sixth International Conference on Jojoba and its Uses. Beer Sheva, Israel: University of the Negev; 1985. p. 393-7.
12. Borlaug N, Baldwin AR, Estefan R, Harris M, Plucknett DL. Jojoba: new crop for arid lands. New raw material for industry. Washington, DC: National Academy Press; 1985. p. 53.
13. Walport MJ, Duff GW. Cells and mediators of inflammation. In: Maddison PJ, Isenberg DA, Woo P, Glass DN, editors. Oxford textbook of rheumatology, vol. 1. Oxford, NY: Oxford University Press; 1993. p. 285-95.
14. Majno G, Joris I. Cells, tissues and disease: principles of general pathology. Cambridge, MA: Blackwell Science; 1996. p. 293.
15. Serhan C.N., Levy B. Success of prostaglandin E2 in structure-function is a challenge for structure-based therapeutics. Proc. Natl. Acad. Sci.: USA. 100(15):2003;8609-8611
16. Goulet J.L., Snouweart J.N., Latour A.M., Coffman T.M. Altered inflammatory responses in leukotriene-deficient mice. Proc. Natl. Acad. Sci.: USA. 91:1994;12852-12856
17. Amin A.R., Vyas P., Attur M., Leszczynsca-Piziak J. The modes of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proc. Natl. Acad Sci.: USA. 92:1995;7926-7930
18. Marucha P.T., Zeff R.A., Kreutzer D.L. Cytokine-induced IL-1β gene expression in the human polymorphonuclear leukocyte: transcriptional and post-transcriptional regulation by tumor necrosis factor and IL-1. J. Immunol. 147:1991;2603-2608
19. Davies N.M., Saleh J.Y., Skjodt N.M. Detection and prevention of NSAID-induced enteropathy. J. Pharm. Pharm. Sci. 3(1):2000;137-155
20. James M.W., Hawkey C.J. Assessment of non-steroidal anti-inflammatory drug (NSAID) damage in the human gastrointestinal tract. Br. J. Clin. Pharmacol. 56(2):2003;146-155
21. Wallace J.L. Selective cyclooxygenase-2 inhibitors: after the smoke has cleared. Dig. Liver Dis. 34(2):2002;89-94
22. Bermond P. Analgesic and antiinflammatory properties of vitamins. Int. J. Vitam. Nutr. Res. Suppl. 30:1989;153-160
23. Bauer B.A. Herbal therapy: what a clinician needs to know to counsel patients effectively. Mayo Clin. Proc. 75(8):2000;835-841
24. Sallee EM. Official and tentative methods of the American oil chemists' society, 3rd ed. Champaign, IL: American Oil Chemists' Society Press; 1980. Method Cc9a-48.
25. Winter C.A., Risley E.A., Nuss G.W. Carrageenin-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:1962;544-547
26. 2. J. Immunol. 155:1995;4437-4444
27. Virella G. Immunoserology. In: Virella G, editor. Medical immunology, 4th ed. New York: Marcel Dekker Inc.; 1998. p. 259-81.
28. D'Arcy P.F., Howard E.M. A new anti-inflammatory test, utilizing the chorio-allantoic membrane of the chick embryo. Br. J. Pharm. Chemother. 29:1967;378-387
29. Tonelli G., Thibault L., Ringler I. A bio-assay for the concomitant assessment of the antiphlogistic and thymolytic activities of topically applied steroids. Endocrinology. 77:1965;625-630
30. Escrig V., Ubeda A., Ferrandiz M.L., Darias J., Sanchez J.M., Alcaraz M.J., et al. Variabilin: a dual inhibitor of human secretory and cytosolic phospholipase A2 with anti-inflammatory activity. J. Pharmacol. Exp. Ther. 282(1):1997;123-131
31. Bradely P.P., Priebat D.A., Christensen R.D., Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78(3):1982;206-209
32. McVey D.C., Vigna S.R. The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats. Peptides. 22:2001;1439-1446
33. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275
34. Edawards J.C.W., Sedgwick A.D., Willoughby D.A. The formation of a structure with the features of synovial lining by subcutaneous injection of air: an in vivo tissue culture system. J. Pathol. 134:1981;147-156
35. 15N ] nitrate in biological fluids Anal. Biochem. 126:1982;131-138
36. Herschman H.R. Prostaglandin synthase 2. Biochim. Biophys. Acta. 1299(1):1996;125-140
37. Bizzi A, Cini M, Bracco U. Absorption and distribution of jojoba oil after oral administration to rats. In: Wisniak J, Zabicky J, editors. Proceedings of the Sixth International Conference on Jojoba and its Uses. Beer Sheva, Israel: University of the Negev; 1985. p. 333-6.
38. Ringbom T., Huss U., Stenholm A., Flock S., Skattebol L., Perera P., et al. COX-2 inhibitory effects of naturally occurring and modified fatty acids. J. Nat. Prod. 64:2001;745-749
39. McGinley K.J., Webster G.F., Ruggieri M.R., Leyden J.J. Regional variations in density of cutaneous propionibacteria: correlation of propionibacterium acnes populations with sebaceous secretions. J. Clin. Microbiol. 12(5):1980;672-675
40. Lawley T.J., Kubota Y. Cell adhesion molecules and cutaneous inflammation. Semin. Dermatol. 10(3):1991;256-259
41. Nauseef W.M., Olsson I., Arnljots K. Biosynthesis and processing of myeloperoxidase-a marker for myeloid cell differentiation. Eur. J. Haematol. 40(2):1988;97-110
42. Klebanoff S.J. Myeloperoxidase. Proc. Assoc. Am. Physicians. 111(5):1999;383-389
43. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142
44. Kou P.C., Schroeder R.A. The emerging multifaceted roles of nitric oxide. Annal. Sur. 221(3):1995;220-235
45. Miller M.J.S., Grisham M.B. Nitric oxide as a mediator of inflammation? You had better believe it. Mediators Inflamm. 4:1995;387-396
46. Sautebin L., Ialenti A., Ianaro A., Di Rosa M. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br. J. Pharmacol. 114(2):1995;323-328
47. Salvemini D., Settle S.L., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Regulation of prostaglandin production by nitric oxide: an in vivo analysis. Br. J. Pharmacol. 114(6):1995;1171-1178
48. Holtmann M.H., Schuchmann M., Zeller G., Galle P.R., Neurath M.F. The emerging distinct role of TNF-receptor 2 (p80) signaling in chronic inflammatory disorders. Arch. Immunol. Ther. Exp. (Warsz). 50(4):2002;279-288
49. Arai K.I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:1990;783-836
50. Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 56(5):1994;559-564
51. Gamble J.R., Harlan J.M., Klebanoff S.J., Vadas M.A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci.: USA. 82(24):1985;8667-8671
52. Dinarello C.A. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 112(Suppl. 6):1997;321S-329S